ArticleBlood research2024

Treatment with ropeginterferon alfa-2b in patients with hydroxyurea resistant or intolerant polycythemia vera in South Korea: one-year results from a phase 2 study.

Seug Yun Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.